There is no single, diagnostic test. Doctors make a diagnosis based on various measures. This can include a prostate-specific ...

An estimated 1 in 8 men will be diagnosed with prostate cancer in their lifetime, often after 65. And as terrifying as that number is, a diagnosis isn’t always quite what it seems. Today, the vast ...

October marks Global Breast Cancer Awareness Month with several ASX companies working to advance early detection and ...

As a health educator, Jesse Bennett was familiar with lab readings. All of his professional life, he has known the importance of annual blood screenings to check the health of his heart, lungs and ...

Magnetic resonance imaging (MRI) holds great potential to spare men with suspected prostate cancer a painful biopsy. In our ...

"Incontinence" doesn't apply strictly to urinary symptoms. A Cleveland Clinic colorectal surgeon speaks to unpredictable bowel movements, too.

Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, ...

These figures are preliminary and unaudited, and actual revenues may differ. The Company plans to announce its full third quarter 2025 financial results after market close on Thursday, November 13, ...

A British father-of-two was diagnosed with prostate cancer after his “gut feeling” led him to push for treatment, despite initial recommendations for “active surveillance”. Fifty-four-year-old Jason ...

SAN FRANCISCO, September 28, 2025 — A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate cancer will benefit from adding hormone ...